J K Wright

Author PubWeight™ 93.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lactose carrier protein of Escherichia coli. Structure and expression of plasmids carrying the Y gene of the lac operon. Eur J Biochem 1980 3.24
2 Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest 1994 2.33
3 In vitro and in vivo products of E. coli lactose permease gene are identical. Nature 1980 2.18
4 The structure of the lactose permease derived from Raman spectroscopy and prediction methods. EMBO J 1985 1.79
5 The mechanism of inducer exclusion. Direct interaction between purified III of the phosphoenolpyruvate:sugar phosphotransferase system and the lactose carrier of Escherichia coli. EMBO J 1983 1.78
6 Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 1998 1.63
7 Anti-peptide antibodies and proteases as structural probes for the lactose/H+ transporter of Escherichia coli: a loop around amino acid residue 130 faces the cytoplasmic side of the membrane. Biochemistry 1986 1.53
8 Peptide-specific antibody locates the COOH terminus of the lactose carrier of Escherichia coli on the cytoplasmic side of the plasma membrane. J Biol Chem 1983 1.51
9 Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997 1.47
10 Nashville experience with liver transplantation in Veterans Administration patients. J Surg Res 1997 1.39
11 A comparison of single photon and dual X-ray absorptiometry of the forearm in children and adults. Bone 1994 1.38
12 Sidedness of native membrane vesicles of Escherichia coli and orientation of the reconstituted lactose: H+ carrier. Eur J Biochem 1984 1.37
13 Purification of the lactose:H+ carrier of Escherichia coli and characterization of galactoside binding and transport. Eur J Biochem 1984 1.34
14 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg 1999 1.32
15 Molecular aspects of sugar:ion cotransport. Annu Rev Biochem 1986 1.29
16 Lactose carrier protein of Escherichia coli: interaction with galactosides and protons. Biochemistry 1981 1.28
17 Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med 1999 1.19
18 Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996 1.19
19 A comparison of 399 open and 568 laparoscopic gastric bypasses performed during a 4-year period. Surg Endosc 2007 1.13
20 Distinct functions of monoclonal IgG antibody depend on antigen-site specificities. J Exp Med 1979 1.12
21 Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 1990 1.11
22 Bile duct injury following laparoscopic cholecystectomy: a cause for continued concern. Am Surg 2001 1.08
23 Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg 1999 1.08
24 Isolation of the globular region of the subcomponent q of the C1 component of complement. Hoppe Seylers Z Physiol Chem 1979 1.08
25 The size of the lactose permease derived from rotational diffusion measurements. EMBO J 1985 1.08
26 Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase. Matrix 1992 1.07
27 Does the lactose carrier of Escherichia coli function as a monomer? FEBS Lett 1983 1.07
28 Management of bronchobiliary fistula as a late complication of hepatic resection. Am Surg 1998 1.05
29 Repeat hepatic surgery for colorectal cancer metastasis to the liver. Ann Surg 1996 1.04
30 Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement. Biochem J 1980 1.02
31 Lactose permease of Escherichia coli: properties of mutants defective in substrate translocation. Proc Natl Acad Sci U S A 1987 1.00
32 Radical resection improves survival for patients with pT2 gallbladder carcinoma. Am Surg 2001 0.97
33 Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays. J Clin Lab Immunol 1983 0.95
34 Antibody-dependent and phytohaemagglutinin-induced lymphocyte cytotoxicity in systemic sclerosis. Clin Exp Immunol 1979 0.93
35 Lactose permease of Escherichia coli. Methods Enzymol 1983 0.92
36 Management of fractures with associated arterial injury in combat casualties. J Trauma 1973 0.92
37 Localization of the galactoside binding site in the lactose carrier of Escherichia coli. Biochim Biophys Acta 1984 0.91
38 Antiperistaltic Roux-en-Y biliary-enteric bypass after bile duct injury: a technical error in reconstruction. Am Surg 1999 0.90
39 Self-mutilation. J Trauma 1983 0.90
40 Surgical experience with hepatic colorectal metastasis. Am Surg 1999 0.90
41 The kinetic mechanism of galactoside/H+ cotransport in Escherichia coli. Biochim Biophys Acta 1986 0.89
42 Scrotal reconstruction with a rectus abdominis muscle flap. Br J Plast Surg 1988 0.89
43 Cervicothoracic sympathectomy in neurovascular abnormalities of the upper extremities: experiences in 76 patients with 104 sympathectomies. Ann Surg 1967 0.88
44 Outcomes analysis for 50 liver transplant recipients: the Vanderbilt experience. Am Surg 1996 0.87
45 Acute pancreatitis after cardiac transplantation and other cardiac procedures: case-control analysis in 24,631 patients. Am Surg 1999 0.87
46 Recurrent gallbladder carcinoma at laparoscopy port sites diagnosed by positron emission tomography: implications for primary and radical second operations. Am Surg 1997 0.87
47 Lactose carrier protein of Escherichia coli. Reconstitution of galactoside binding and countertransport. Eur J Biochem 1982 0.87
48 Lactose transport in Escherichia coli: effect of transmembrane potential difference on apparent substrate affinity. Biochem Soc Trans 1980 0.86
49 Reduced immunoglobulin G activates complement system with decreased cooperativity. Biochem Biophys Res Commun 1978 0.86
50 Selective reduction and proteolysis in the hinge region of liganded and unliganded antibodies: identical kinetics suggest lack of major conformational change in the hinge region. Eur J Immunol 1978 0.86
51 Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg 1998 0.86
52 The lactose/H+ carrier of Escherichia coli: lac YUN mutation decreases the rate of active transport and mimics an energy-uncoupled phenotype. Biochem J 1985 0.86
53 Outcomes analysis in 100 liver transplantation patients. Am J Surg 1998 0.85
54 Lactose permease and the molecular biology of transport. Hoppe Seylers Z Physiol Chem 1982 0.85
55 Use of the soleus muscle flap to cover part of the distal tibia. Plast Reconstr Surg 1981 0.85
56 Polyclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure TIMP-collagenase complex. Matrix 1992 0.84
57 Vascular injury in Vietnam combat casualties: results of treatment at the 24th Evacuation Hospital 1 July 1967 to 12 August 1969. Ann Surg 1973 0.84
58 Preparation and characterization of chemically defined oligomers of rabbit immunoglobulin G molecules for the complement binding studies. Biochem J 1980 0.83
59 Experimental analysis of ion/solute cotransport by substrate binding and facilitated diffusion. Biochim Biophys Acta 1986 0.83
60 Polyclonal and monoclonal antibodies against human tissue inhibitor of metalloproteinases (TIMP) and the design of an enzyme-linked immunosorbent assay to measure TIMP. Matrix 1991 0.83
61 Effects of heparin, histamine, and salmon calcitonin on mouse calvarial bone resorption. Ann Rheum Dis 1986 0.83
62 Clinical experience with cryosurgery for advanced hepatobiliary tumors. J Surg Res 1998 0.82
63 Independence of the binding of domain-specific ligands to Fab and Fc suggests that antigen-induced effects in IGG antibodies are not allosteric. FEBS Lett 1978 0.82
64 Chemical modification of the lactose carrier of Escherichia coli by plumbagin, phenylarsinoxide or diethylpyrocarbonate affects the binding of galactoside. Eur J Biochem 1983 0.82
65 An elementary theory leading to non-linear dose-risk relationships for radiation carcinogenesis. Br J Cancer 1969 0.82
66 Hepatocellular carcinoma outcomes based on indicated treatment strategy. Am Surg 1998 0.81
67 Isolation and growth characteristics of adult human tendon fibroblasts. Ann Rheum Dis 1987 0.81
68 Rupture and hemorrhage of hepatic focal nodular hyperplasia. Am Surg 1995 0.81
69 Serum-induced enhancement of peripheral blood mononuclear cell-mediated cytotoxicity towards human target cells in systemic sclerosis. J Clin Lab Immunol 1983 0.80
70 Overview of liver transplantation for the perfusionist. J Extra Corpor Technol 1992 0.80
71 Survival of full-thickness skin grafts over avascular defects. Plast Reconstr Surg 1980 0.80
72 Amino acid sequences of antibody light chain variable regions of pedigreed rabbits: kappa light chain K49-501 (allotype b4 anti-streptococcal group A-variant polysaccharide antibody). Hoppe Seylers Z Physiol Chem 1979 0.80
73 Lactose: H+ carrier of Escherichia coli: kinetic mechanism, purification, and structure. Ann N Y Acad Sci 1985 0.80
74 Comparison of arcuate-legged clipped versus sutured hepatic artery, portal vein, and bile duct anastomoses. Am Surg 1999 0.79
75 Spontaneous lymphocyte-mediated (NK cell) cytotoxicity in systemic sclerosis: a comparison with antibody-dependent lymphocyte (K cell) cytotoxicity. Ann Rheum Dis 1982 0.79
76 Ileal conduit venous varices from portal hypertension as a cause of recurrent, massive hemorrhage: case report and review of the literature. J Urol 1994 0.78
77 High affinity anti-carbohydrate antibodies identified in anti-A-variant streptococcal antisera. FEBS Lett 1978 0.78
78 Distribution of liposome-incorporated carboxyfluorescein in rabbit eyes. J Microencapsul 1991 0.78
79 Intestinal reperfusion-induced pulmonary edema is related to increased pulmonary inducible nitric oxide synthase activity. Surgery 1998 0.78
80 Mechanisms of hyperinsulinemia and hyperglucagonemia after liver transplantation. J Surg Res 1997 0.77
81 Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus). Transplant Proc 1998 0.77
82 A method for the evaluation of minor degrees of breast asymmetry. Plast Reconstr Surg 1977 0.77
83 Ischemic preconditioning improves preservation with crystalloid cardioplegia. Ann Thorac Surg 1994 0.77
84 Properties of a mutant lactose carrier of Escherichia coli with a Cys148----Ser148 substitution. FEBS Lett 1985 0.77
85 Interaction of substrates and inhibitors with the homoserine dehydrogenase of kinase-inactivated aspartokinase I. Biochemistry 1977 0.77
86 OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients. Transplant Proc 1991 0.77
87 Supra-elevated CA 19-9 in a benign hepatic cyst adenoma. HPB (Oxford) 2004 0.76
88 Patent blue V encapsulation in liposomes: potential applicability to endolympatic therapy and preoperative chromolymphography. Lymphology 1988 0.76
89 A model for the extended studies of hepatic hemodynamics and metabolism in swine. Lab Anim Sci 1996 0.76
90 Lymphocyte cytotoxicity in systemic sclerosis: no increase on short-term culture with established human cell lines. Ann Rheum Dis 1982 0.75
91 Antibody-dependent and phytohaemagglutinin-induced lymphocyte cytotoxicity in systemic lupus erythematosus. Ann Rheum Dis 1981 0.75
92 Impaired immunity in patients with inflammatory bowel disease and hyposplenism: the response to intravenous phi X174. Gut 1981 0.75
93 Heart-lung-liver transplant for cystic fibrosis. Transplant Proc 2001 0.75
94 The effect of low dose epinephrine infusion on hepatic hemodynamics. Transplant Proc 1998 0.75
95 Vanderbilt experience with cryosurgery for 25 advanced hepatic tumors. Tenn Med 1998 0.75
96 Experience with neoral versus sandimmune in primary liver transplant recipients. Transpl Int 1998 0.75
97 HUMAN NATURE IN SCIENCE. Science 1944 0.75
98 Rheumatoid factor quantitation: a comparison of ELISA and nephelometric methods. Med Lab Sci 1991 0.75
99 Immediate effect of intravenous cyclosporine on hepatic hemodynamics. Transplant Proc 1996 0.75
100 Clonal dominance of low-affinity antibodies in rabbit hyperimmune anti-streptococcal group A-variant polysaccharide antisera. Eur J Immunol 1979 0.75
101 Hepatic uptake of amino acids immediately after liver transplantation is well preserved despite altered plasma profiles. J Surg Res 1998 0.75
102 Isolation of a substrate-containing active-site peptide from aspartokinase I. Biochem Biophys Res Commun 1976 0.75
103 The management of acute penetrating abdominal trauma complicating term pregnancy. J Trauma 1971 0.75
104 Effect of dopamine infusion on hemodynamics after hepatic denervation. J Surg Res 2001 0.75
105 Liver transplantation: results with Vanderbilt's first 25 liver recipients. J Tenn Med Assoc 1994 0.75
106 Prevention of hypocalcemia in children due to parathyroid infarction after thyroidectomy. Surg Gynecol Obstet 1979 0.75
107 A preliminary study of the treatment of trochanteric fractures of the femur with the Kenwright nail. Injury 1982 0.75
108 The measurement of human collagenase-TIMP complex by enzyme immunoassay. Biochem Soc Trans 1991 0.75
109 Primary closure of gastroschisis. Evaluation of results and technique. Surg Annu 1979 0.75
110 The differential responses of human skin and synovial fibroblasts to stanozolol in vitro: production of prostaglandin E2 and matrix metalloproteinases. Agents Actions 1992 0.75
111 Cobalt(III) affinity-labeled aspartokinase. Formation of substrate and inhibitor adducts. Biochemistry 1976 0.75
112 Preclinical evaluation of immunosuppression selective for T cells recognizing class I histocompatibility antigens. Transplant Proc 1987 0.75
113 Effect of dopamine infusion (3-30 microg/kg/min) on hepatic hemodynamics. J Surg Res 2000 0.75
114 Cholecystectomy with closed suction drainage. South Med J 1980 0.75
115 Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients. Transplant Proc 1998 0.75
116 Serum-induced enhancement of peripheral blood mononuclear cell mediated cytotoxicity towards human target cells in systemic lupus erythematosus. J Clin Lab Immunol 1983 0.75
117 Case report: sepsis from a granulating wound in a patient with a white blood cell defect. Mil Med 1988 0.75
118 Lactose carrier protein of Escherichia coli: studies on purification, biosynthesis, and mechanism. Ann N Y Acad Sci 1980 0.75
119 Net hepatic glucose output is normal on postoperative day 1 after liver transplantation. Am Surg 1998 0.75
120 The effect of nutritional and hormonal supplementation on protein synthesis immediately after liver transplantation. J Surg Res 1999 0.75